Valeant Pharmaceuticals (VRX) Improves Q4 EPS to $1.34

February 28, 2013 6:47 AM

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) reported Q4 EPS of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found